X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Torrent Pharma with Wockhardt - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs WOCKHARDT LTD. - Comparison Results

TORRENT PHARMA    Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TORRENT PHARMA WOCKHARDT LTD. TORRENT PHARMA/
WOCKHARDT LTD.
 
P/E (TTM) x 25.8 16.5 156.2% View Chart
P/BV x 6.3 1.7 375.1% View Chart
Dividend Yield % 3.2 0.0 -  

Financials

 TORRENT PHARMA   WOCKHARDT LTD.
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-16
WOCKHARDT LTD.
Mar-16
TORRENT PHARMA/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs1,7202,000 86.0%   
Low Rs1,134706 160.6%   
Sales per share (Unadj.) Rs394.5403.7 97.7%  
Earnings per share (Unadj.) Rs101.829.5 345.4%  
Cash flow per share (Unadj.) Rs116.342.4 274.6%  
Dividends per share (Unadj.) Rs40.000-  
Dividend yield (eoy) %2.80-  
Book value per share (Unadj.) Rs200.3323.4 61.9%  
Shares outstanding (eoy) m169.22110.51 153.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.63.4 107.9%   
Avg P/E ratio x14.045.9 30.5%  
P/CF ratio (eoy) x12.331.9 38.4%  
Price / Book Value ratio x7.14.2 170.3%  
Dividend payout %39.30-   
Avg Mkt Cap Rs m241,435149,509 161.5%   
No. of employees `00010.97.4 147.7%   
Total wages/salary Rs m8,5599,443 90.6%   
Avg. sales/employee Rs Th6,129.66,048.6 101.3%   
Avg. wages/employee Rs Th785.81,280.2 61.4%   
Avg. net profit/employee Rs Th1,581.3441.5 358.2%   
INCOME DATA
Net Sales Rs m66,76444,614 149.6%  
Other income Rs m2,156970 222.4%   
Total revenues Rs m68,92045,584 151.2%   
Gross profit Rs m27,2045,038 539.9%  
Depreciation Rs m2,4611,426 172.6%   
Interest Rs m1,8591,012 183.6%   
Profit before tax Rs m25,0413,570 701.4%   
Minority Interest Rs m0-65 0.5%   
Prior Period Items Rs m06 0.0%   
Extraordinary Inc (Exp) Rs m-1,4030-   
Tax Rs m6,414255 2,517.2%   
Profit after tax Rs m17,2243,257 528.9%  
Gross profit margin %40.711.3 360.8%  
Effective tax rate %25.67.1 358.9%   
Net profit margin %25.87.3 353.4%  
BALANCE SHEET DATA
Current assets Rs m46,62239,906 116.8%   
Current liabilities Rs m32,84318,423 178.3%   
Net working cap to sales %20.648.2 42.9%  
Current ratio x1.42.2 65.5%  
Inventory Days Days7490 82.3%  
Debtors Days Days7998 80.4%  
Net fixed assets Rs m39,02935,832 108.9%   
Share capital Rs m846553 153.2%   
"Free" reserves Rs m31,40030,370 103.4%   
Net worth Rs m33,89035,739 94.8%   
Long term debt Rs m18,63716,542 112.7%   
Total assets Rs m90,13679,522 113.3%  
Interest coverage x14.54.5 319.7%   
Debt to equity ratio x0.50.5 118.8%  
Sales to assets ratio x0.70.6 132.0%   
Return on assets %21.25.4 394.4%  
Return on equity %50.89.1 557.7%  
Return on capital %48.58.7 561.0%  
Exports to sales %43.311.6 373.5%   
Imports to sales %6.94.5 153.9%   
Exports (fob) Rs m28,9345,177 558.9%   
Imports (cif) Rs m4,5841,990 230.3%   
Fx inflow Rs m29,1857,589 384.6%   
Fx outflow Rs m6,0212,878 209.2%   
Net fx Rs m23,1654,711 491.8%   
CASH FLOW
From Operations Rs m27,132716 3,788.9%  
From Investments Rs m-7,014-8,182 85.7%  
From Financial Activity Rs m-14,3522,543 -564.4%  
Net Cashflow Rs m5,767-4,923 -117.1%  

Share Holding

Indian Promoters % 71.5 74.5 96.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.0 2.3 305.2%  
FIIs % 12.6 7.7 163.6%  
ADR/GDR % 0.0 0.1 -  
Free float % 8.8 15.4 57.1%  
Shareholders   26,511 67,757 39.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TORRENT PHARMA With:   SANOFI INDIA  ABBOTT INDIA  FRESENIUS KABI ONCO.  CIPLA  ASTRAZENECA PHARMA  

Compare TORRENT PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Infosys Down 4.1%(09:30 am)

Asian stock markets opened mixed in early trade today. Hong Kong Hang Seng has advanced 143 points and China's Shanghai Composite has gained 9 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Aug 21, 2017 11:05 AM

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 5-YR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS